SAN ANTONIO — Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain disease-free. They will present their findings on December 13, 2019, at the San Antonio Breast Cancer Symposium, the most influential gathering of breast cancer researchers and physicians in the world. Milan Radovich, PhD, and Bryan Schneider, […]
The post Indiana University School of Medicine researchers use cutting-edge technology to predict which triple negative breast cancer patients may avoid recurrence and those who are at high-risk of relapse appeared first on Newsroom.
Researchers at Indiana University School of Medicine have launched a new, unique study recruiting black women with breast cancer designed to better understand and treat neuropathy, a side effect from chemotherapy. The National Cancer Institute-sponsored clinical trial, EAZ171, is led by Bryan P. Schneider, MD, professor of medicine and medical and molecular genetics and the […]
The post Trial seeks to reduce neuropathy, improve outcomes for black women with breast cancer appeared first on Newsroom.